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Introduction: Plummeting sequencing costs have led to a great increase in the number of personal 
genomes. Interpreting the large number of variants in them, particularly in noncoding regions, is a 
current challenge. This is especially the case for somatic variants in cancer genomes, a large propor-
tion of which are noncoding.
Methods: We investigated patterns of selection in DNA elements from the ENCODE project using 
the full spectrum of variants from 1092 individuals in the 1000 Genomes Project (Phase 1), includ-
ing single-nucleotide variants (SNVs), short insertions and deletions (indels), and structural variants 
(SVs). Although we analyzed broad functional annotations, such as all transcription-factor binding 
sites, we focused more on highly specifi c categories such as distal binding sites of factor ZNF274. 
The greater statistical power of the Phase 1 data set compared with earlier ones allowed us to differ-
entiate the selective constraints on these categories. We also used connectivity information between 
elements from protein-protein-interaction and regulatory networks. We integrated all the informa-
tion on selection to develop a workfl ow (FunSeq) to prioritize personal-genome variants on the basis 
of their deleterious impact. As a proof of principle, we experimen-
tally validated and characterized a few candidate variants.
Results: We identifi ed a specifi c subgroup of noncoding categories 
with almost as much selective constraint as coding genes: “ultra-
sensitive” regions. We also uncovered a number of clear patterns of 
selection. Elements more consistently active across tissues and both 
maternal and paternal alleles (in terms of allele-specifi c activity) 
are under stronger selection. Variants disruptive because of mecha-
nistic effects on transcription-factor binding (i.e. “motif-breakers”) 
are selected against. Higher network connectivity (i.e. for hubs) 
is associated with higher constraint. Additionally, many hub pro-
moters and regulatory elements show evidence of recent positive 
selection. Overall, indels and SVs follow the same pattern as SNVs; 
however, there are notable exceptions. For instance, enhancers are 
enriched for SVs formed by nonallelic homologous recombination. 
We integrated these patterns of selection into the FunSeq prioritiza-
tion workfl ow and applied it to cancer variants, because they present 
a strong contrast to inherited polymorphisms. In particular, applica-
tion to ~90 cancer genomes (breast, prostate and medulloblastoma) 
reveals nearly a hundred candidate noncoding drivers.
Discussion: Our approach can be readily used to prioritize vari-
ants in cancer and is immediately applicable in a precision-medi-
cine context. It can be further improved by incorporation of larger-
scale population sequencing, better annotations, and expression 
data from large cohorts.
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Interpreting variants, especially noncoding ones, in the increasing number of personal genomes
is challenging. We used patterns of polymorphisms in functionally annotated regions in 1092
humans to identify deleterious variants; then we experimentally validated candidates. We analyzed
both coding and noncoding regions, with the former corroborating the latter. We found regions
particularly sensitive to mutations (“ultrasensitive”) and variants that are disruptive because of
mechanistic effects on transcription-factor binding (that is, “motif-breakers”). We also found
variants in regions with higher network centrality tend to be deleterious. Insertions and deletions
followed a similar pattern to single-nucleotide variants, with some notable exceptions (e.g., certain
deletions and enhancers). On the basis of these patterns, we developed a computational tool (FunSeq),
whose application to ~90 cancer genomes reveals nearly a hundred candidate noncoding drivers.
Whole-genome sequencing has revealedmillions of variants per individual. How-ever, the functional implications of the
vast majority of these variants remain poorly
understood (1). It is well established that var-
iants in protein-coding genes play a crucial role
in human disease. Although it is known that non-
coding regions are under negative selection and
that variants in them have been linked to disease,
their role is generally less well understood (2–9).
In particular, whereas some studies have dem-
onstrated a link between common variants from
genome-wide association studies (GWASs) and
regulatory regions (2, 3), the deleterious effects
of rare inherited variants and somatic cancer mu-
tations in noncoding regions have not been ex-
plored in a genome-wide fashion. Recently, three
studies reported noncoding driver mutations in
the TERT promoter in multiple tumor types, in-
cluding melanomas and gliomas (10–12). In light
of these studies and the growing availability of
whole-genome cancer sequencing (13–20), an in-
tegrated framework facilitating functional inter-
pretation of noncoding variants would be useful.
One may think to identify noncoding regions
under strong selection purely through mamma-
lian sequence conservation, and ultraconserved
elements have been found in this fashion (21).
However, signatures of purifying selection iden-
tified by using population-variation data could
provide better insights into the importance of a
genomic region in humans than evolutionary con-
servation. This is because many regions of the
genome show human-specific purifying selection,
whereas other regions conserved across mam-
mals show a lack of functional activity and selec-
tion in humans (7). Thus, identifying the specific
elements under particularly strong purifying se-
lection among humans could provide novel insights.
Besides single-nucleotide polymorphisms
(SNPs), the human genome also contains other
variants, including small insertions and deletions
(indels) and larger structural variants (SVs) (22).
They account for more nucleotide differences
among humans than SNPs; hence, an under-
standing of their relationship with functional el-
ements is crucial (23).
We used the full range of sequence polymor-
phisms (ranging from SNPs to SVs) from 1092
humans to study patterns of selection in various
functional categories, especially noncoding reg-
ulatory regions (24). We identified specific ge-
nomic regions where variants are more likely to
have strong phenotypic impact. The list of these
regions includes groups of coding genes and spe-
cific sites within them and, importantly, particular
noncoding elements. By further comparing pat-
terns of polymorphisms with somatic mutations,
we show how this list can aid in the identification
of cancer drivers. We used multiple experimental
methods for validation, including yeast two-hybrid
experiments, Sanger sequencing of independent
cancer samples, and relevant gene-expression mea-
surements. Furthermore, we provide a software
tool that allows researchers to prioritize non-
coding variants in disease studies.
Genomic Elements Under Strong Purifying
Selection: Ultrasensitive Regions
Enrichment of rare variants can be used to esti-
mate the strength of purifying selection in differ-
ent functional categories (24). As expected, we
found that having variants from 1092 individuals
allowed us to detect specific functional catego-
ries under strong purifying selection with greater
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power than previously possible (2, 7, 9). In par-
ticular, the increased number of samples provided
a better estimate of allele frequencies, making pos-
sible the measurement of differential selective
constraints between specific categories [e.g., be-
tween motifs of transcription-factor (TF) fami-
lies HMG and MADs box] (figs. S4 and S5).
Estimates of purifying selection obtained by
using enrichment of rare nonsynonymous SNPs
(derived allele frequency or DAF < 0.5%) showed
that different gene categories exhibit differential
selection consistent with their known phenotypic
consequences (data S1). Genes tolerant of loss-
of-function (LoF) mutations are under the weakest
selection, whereas cancer-causal genes are under
the strongest (Fig. 1A and table S1). GWAS genes
associated with complex disorders lie in between
these extremes, consistent with the presence of
common genetic variants in them.
We then analyzed selective constraints in non-
coding regions, trying to find elements under very
strong selection (i.e., with a fraction of rare variants
similar to that of coding genes, ~67%). We first es-
timated the strength of negative selection in broad
categories [e.g., in all TF binding sites (TFBSs),
deoxyribonuclease I (DNaseI)–hypersensitive sites
(DHSs), noncoding RNAs (ncRNAs), and en-
hancers] (Fig. 2A). As observed previously, most of
these categories show slight but statistically sig-
nificant enrichment of rare SNPs compared with the
genomic average; in contrast, pseudogenes dem-
onstrate a depletion (Fig. 2A and data S2) (2).
We further divided the broad categories into
677 high-resolution ones. These span various ge-
nomic features likely to influence the extent of
selection acting on the element. For example,
TFBSs of different TF families are divided into
proximal versus distal and cell-line–specific versus
–nonspecific (fig. S7). We find heterogeneous
degrees of negative selection for specific cat-
egories (Fig. 2B and data S2). For instance, core
motifs in the binding sites of TF families HMG
and Forkhead are under particularly strong se-
lection, whereas those in the CBF-NFY family
do not exhibit selective constraints (relative to
the genomic average) (Fig. 2B). Among all the
pseudogenes, polymorphic ones have the highest
fraction of rare alleles, consistent with their func-
tional coding roles in some individuals (25). Over-
all, we found that 102 of the 677 categories show
statistically significant selective constraints (data
S2) (figs. S8 to S10).
Among these 102 categories, we defined the
top ones covering ~0.02% and ~0.4% of the ge-
nome as ultrasensitive and sensitive, respective-
ly (fig. S11) (data S3). Thus, these regions were
defined such that they possess a high fraction of
rare variants comparable to that for coding se-
quences (67.2% for coding and 65.7% for ultra-
sensitive) (Fig. 2C). We validated the rare variants
in them by comparison with Complete Genomics
data. Sensitive regions include binding sites of
some chromatin and general TFs (e.g., BRF1 and
FAM48A) and core motifs of some important TF
families (e.g., JUN, HMG, Forkhead, and GATA).
For some TFs, there is a strong difference be-
tween proximal and distal binding sites—for ex-
ample, for ZNF274, proximal binding sites are
under strong selection and belong to the ultrasen-
sitive category, whereas distal sites are not under
negative selection.
In order to validate the functional importance
of sensitive and ultrasensitive regions, we exam-
ined the presence of inherited disease-causing
mutations from HGMD (Human Gene Muta-
tion Database) in them (26). We found ~40- and
~400-fold enrichment of disease-causing muta-
tions in sensitive and ultrasensitive regions, re-
spectively (compared with the entire noncoding
sequence, P < 2.2 × 10–16) (Fig. 2E). Thus, these
documented disease-causing variants provide in-
dependent validation for the functional impor-
tance of sensitive regions. As a specific example,
the disease congenital erythropoietic porphyria
is caused by disruption of a binding site classi-
fied as sensitive (the GATA1 motif upstream of
uroporphyrinogen-III synthase) (27). Similarly,
the well-known disease-causing ncRNA RMRP
is in the binding site of BRF2, classified as ultra-
sensitive (28).
Purifying Selection and Other Aspects
of Regulatory Regions
We analyzed sites at which SNPs break or con-
serve core-binding motifs. As expected, we found
that disruptive motif-breaking SNPs are signif-
icantly enriched for rare alleles compared with
motif-conserving ones (P < 2.2 × 10–16; Fig. 2D;
a motif-breaking SNP is defined as a change that
decreases the matching score in the motif posi-
tion weight matrix). This result is over all TF fam-
ilies; moreover, we find the difference between
constraints on motif-breaking versus -conserving
SNPs varies considerably for different TF fam-
ilies, possibly reflecting differences in the topol-
ogy of their DNA binding domains (data S4).
We also found that expression quantitative
trait loci (eQTLs) are enriched in the binding
sites of many TF families (Fig. 2B); the asso-
ciation of TF binding and gene expression at
these loci provides a plausible explanation for
their phenotypic effects.
An analysis of SNPs from a personal genome
(NA12878) exhibiting allele-specific TF bind-
ing in chromatin immunoprecipitation sequenc-
ing (ChIP-Seq) data or allele-specific expression
in RNA-seq data (with the allele-specific “activ-
ity” tagging a difference between maternal and
paternal chromosomes at the genomic region in
question) showed that these sites are depleted for
rare variants (relative to a matched control) (Fig.
2F). This suggests that regions where differen-
tial allelic activity is not observed may be under
stronger purifying selection (29).
In a similar fashion, we found that core-motif
regions bound in a “ubiquitous manner” (i.e.,
where differential cell-type–specific binding is
not observed) are under stronger selection than
those bound by TFs in a single cell line (data S2),
consistent with the greater functional importance
of ubiquitously bound regions. In relation to this,
we further examined how selective constraints
vary among coding genes and DHSs with tissue-
specific activity (Fig. 1B). We found there are
pronounced differences between tissues: For ex-




























































































































































































































































































Fig. 1. Fraction of rare (DAF < 0.5%) SNPs. (A) In various gene cate-
gories. Total number of SNPs in each category shown. (B) In noncoding DHSs and
coding genes, which show tissue-specific behavior. Matching tissues for which both
DHS and gene expression data are available shown in same colors: shades of green
for endodermal, gray for mesodermal, and blue for ectodermal origin of tissues.
Red dotted lines show the total fraction for all DHSs and coding genes. Asterisks
show significant depletion or enrichment after multiple-hypothesis correction.
Error bars in both (A) and (B) denote 95% binomial confidence intervals.
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pression are under significantly stronger selec-
tion than the average across all tissues (Fig. 1B
and table S4). Similarly, some DHSs are under sig-
nificantly stronger selection, whereas others are
under relaxed constraints relative to the average
(brain- and kidney-specific versus urothelium- and
breast-specific, respectively; Fig. 1B and table
S4). Last, matched expression and DHS data
for six tissues indicate that purifying selection in
tissue-specific genes and their corresponding reg-
ulatory regions is likely correlated (fig S15). Thus,
our results suggest that the deleteriousness of
both coding and regulatory variants depends on
the tissues they affect.
Purifying Selection in the Interactome
and Regulome
We found a significant positive correlation be-
tween the fraction of rare SNPs and the degree
centrality of genes in networks: physical protein-
protein interaction (PPI) (rho = 0.15; P < 2.2 ×
10–16) and regulatory (rho = 0.07; P = 6.8 × 10–08).
Thus, consistent with previous studies, we found
that hub genes tend to be under stronger nega-
tive selection (29–31). Indeed, centralities of dif-
ferent gene categories in the PPI network follow
the same trend as differential selective constraints
on them: Cancer-causal genes show the highest
connectivity, and LoF-tolerant genes, the least,
with GWAS genes in the middle (Figs. 1A and 3A).
These results indicate that the interactions of a
gene likely influence the selection acting on it.
Hub proteins tend to have more interaction
interfaces in the PPI network (31). A corollary of
this is that interaction interfaces are themselves
under strong selection, in turn leading to stronger
constraints on hub proteins. Indeed, we found that
SNPs disrupting interaction interfaces are en-
riched for rare alleles (P < 2.2 × 10–16) (Fig. 3B).
To further corroborate this, we tested a specific
case, the Wiskott-Aldrich syndrome protein
(WASP), using yeast two-hybrid (Y2H) experi-
ments (32). All of the three tested single-
nucleotide variants (SNVs) at WASP interaction
interfaces disrupted its interactions with other pro-
teins (Fig. 3C). We observed similar behavior for
two other proteins: Mutations at their interfaces
disrupted specific protein interactions (fig. S16).
Relationship of Functional Elements
with Indels and Larger SVs
We analyzed the association of functional anno-
tations with small indels [<50 base pairs (bp)]
and large SVs (deletions). Similar to the results
for nonsynonymous SNPs, we found that genes
linked with diseases show stronger selection
against indels whereas LoF-tolerant genes show
weaker constraints (relative to all genes), with
a consistent trend for indels overall and frame-
shift indels, in particular (Fig. 4A, fig. S17, and
table S1).
The wide range of SV sizes (~50 bp to ~1 Mb)
leads to their diverse modes of intersection with
functional elements; for example, a single SV
breakpoint can split an element, a smaller SV
can cut out a portion of a single element, and a
large SV can engulf an entire element. To ana-
lyze the diverse effects of SVs, we computed the
enrichment or depletion of SVs overlapping each
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Fig. 2. Fraction of rare SNPs in noncoding cat-
egories. Red dotted lines represent genomic av-
erage. Error bars denote 95% binomial confidence
intervals. Total numbers of SNPs in each category
shown. (A) Broad categories. Ultrasensitive and
sensitive regions are those under very strong nega-
tive selection. TFSS, sequence-specific TFs. Categories
tested for enrichment of HighD sites (Fig. 5A) marked
by using hollow triangles on the left. (B) Example of
high-resolution categories: TFBS motifs separated into
15 families. e superscripts in red denote enrichment
of eQTLs in TFBSs of specific families. (C) Examples of
TFBSs included in ultrasensitive category. (D) SNPs breaking TF motifs show an
excess of rare alleles compared with those conserving them. Representative motifs
for two families are shown. (E) Enrichment of HGMD regulatory disease–causing
mutations in ultrasensitive, sensitive, and annotated regions compared with all
noncoding regions. (F) SNPs not exhibiting allele-specific behavior (–) are en-
riched in rare alleles compared with SNPs exhibiting allele-specific behavior (+).
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functional category relative to a randomized con-
trol. As expected, we found that genic regions
[coding sequences, untranslated regions (UTRs),
and introns] are depleted for SVs, suggesting
SVs affecting gene function are deleterious (Fig.
4B) (22). However, when we broke down the
mode of SV intersection with genes into partial
versus whole (an SV breakpoint splitting a gene
versus an SV engulfing a whole gene), we unex-
pectedly found that SVs are enriched for whole-
but depleted for partial-gene overlap. This suggests
that partial-gene overlap is under stronger selec-
tion than whole-gene overlap, possibly because
whole-gene deletions may be compensated by du-
plications. Furthermore, another category of gene-
related elements, pseudogenes, are enriched for
SVs, consistent with their formation mechanism
involving either duplication or retrotransposition.
In relation to nongenic elements, we found that
SVs tend to be depleted in regulatory elements
such as binding-site motifs and enhancers (Fig.
4B), consistent with our expectations from SNPs.
However, enhancer elements are enriched for SVs
formed by nonallelic homologous recombination
(NAHR). This observation is further supported by
the high signal of activating histone marks asso-
ciated with enhancers (e.g., H3K4me1) around
NAHR breakpoints (Fig. 4C and fig. S18). The
association of enhancers and NAHR deletions
may be explained by the three-dimensional struc-
ture of chromatin bringing enhancer elements
into close proximity with the gene transcription
start site (via DNA “looping”). If these two “non-
allelic” loci contain homologous sequences, it
would be favorable for NAHR to occur.
Functional Implications of Positive Selection
Among Human Populations
Negative selection is widespread in the genome;
nevertheless, some positions within negatively
selected regions also experience positive selec-
tion (33–36). We have previously identified and
validated one category of variants that are strong
candidates for positive selection: sites where con-
tinental populations show extreme differences in
DAF (HighD sites) (24). By analyzing these HighD
sites, we are focusing on positive selection under
the classic selective-sweep model (37). Positive
selection via other modes (such as selection on
standing variation) likely also played a major
role in recent human evolution (38). Nonethe-
less, functional annotation of HighD sites can
provide important insights about recent adapta-
tions (39).
We examined positive selection in the same
fashion as we have done for negative selection:
in coding genes, noncoding regulatory elements,
and networks of gene interactions. The func-
tional analysis of positive selection using highly
differentiated sites is limited to SNPs, because
of the low numbers of such indels and SVs in
functional elements.
We observed enrichment of HighD sites in
UTRs and missense SNPs in coding regions
(Fig. 5A). Next, we observed that some disease
gene groups (Online Mendelian Inheritance in
Man, HGMD, and GWAS) are enriched for HighD
SNPs (fig. S20). Mutations in disease genes are
likely to have strong phenotypic impact; thus, it
is possible that some of these mutations confer
advantage for local adaptation. For example,
whereas LoF mutations in ABCA12 lead to the
severe skin disorder harlequin ichthyosis (40),
we found that a SNP within the second intron of
this gene is a HighD site (DAF > 90% in Europe
and East Asia; 13% in Africa), possibly reflect-
ing adaptations of the skin to levels of sunlight
outside of Africa.
Similar to our analysis of negative selection,
we analyzed the enrichment of HighD sites in
broad and specific noncoding categories, finding
significant enrichment in many noncoding cate-
gories (Fig. 5A). These enriched categories in-
clude DHSs (particularly distal ones) and binding
sites of sequence-specific TFs (specifically those
in ZNF and NR families). Out of the seven en-
riched categories, five are also under significant
negative selection (Figs. 2A and 5A and data
S2). Thus, even though an entire category might
be under negative selection, some particular sites
within it can be targets of positive selection. In
this respect, our results are consistent with pre-
vious studies for missense SNPs: Overall they
are under strong negative selection, but a small
group of them have been targets of positive se-
lection (36).
We found that, as expected, coding genes with
HighD SNPs tend to have lower degree centrality
in both PPI and regulatory networks (although
the small number of these cases does not produce
statistical significance) (Fig. 5B and fig. S21) (41).
In an opposite trend to genes (where positive se-
lection occurs on the network periphery), HighD
sites in TFBSs tend to occur in hub promoters (P =




























































































































































Fig. 3. SNPs in protein-protein interaction (PPI) network. (A) Degree centrality of coding-gene
categories in PPI network. (B) Fraction of rare missense SNPs at protein-interaction interfaces is higher
than all rare missense SNPs (error bars show 95% binomial confidence intervals; total number of SNPs
also shown). (C) Effects of SNVs at interaction interfaces on interactions of WASP with other proteins
tested by Y2H experiments. Wild-type (WT) WASP interacts with all proteins shown, whereas each
missense SNV disrupts its interaction with at least one protein.
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37 proximal TFBSs) (Fig. 5B). It was previously
proposed that mutations in cis elements in reg-
ulatory networks may play an important role in
development (42, 43); our study supports this by
suggesting that some hub promoters may have
undergone recent adaptive evolution.
Contrasting Patterns of Somatic Mutations
with Inherited Variants
After analyzing inherited polymorphisms in func-
tional elements, we examined somatic variants. Be-
cause somatic variants from diverse tumors exhibit
different sets of properties, we analyzed variants
from a wide range of cancer types: prostate, breast,
and medulloblastoma (17, 19, 20). We found that
~99% of somatic SNVs occur in noncoding re-
gions, including TFBSs, ncRNAs, and pseudo-
genes (fig. S22).
Analysis of matched tumor and normal tis-
sues from the same individuals showed that so-
matic variants tend to be enriched for missense
(~5×), LoF (~14×), sensitive (~1.2×), and ultrasen-
sitive (~2×) variants (Fig. 6A, fig. S24, and table
S6). Consistent with this trend, we found higher
TF-motif-breaking/conserving ratios for somatic
variants compared with germline ones across many
different samples and cancer types (~3 for somatic
versus ~1.4 for germline) (Fig. 6B and table S7).
Thus, somatic-cancer variants are generally en-
riched for functionally deleterious mutations.
This enrichment of functionally deleterious
mutations among somatic variants is understand-
able because they are not under organism-level
natural selection (unlike inherited-disease muta-
tions, including GWAS variants). Indeed, among
all somatic mutations, those most deviating from
patterns of natural polymorphisms are the most
likely to be cancer drivers. Consistent with this,
our analysis has shown that, among all disease
mutations, those causing cancer occur in genes
under strongest negative selection (and with highest
network connectivity) (Figs. 1A and 3A). Thus,
we argue that somatic variants in the noncoding
elements under strongest selection are the most
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Fig. 4. Functional annotations of indels and
SVs. (A) Fraction of rare indels in coding-gene
categories. Total number of indels shown. (B) En-
richment of SVs affecting functional annotations.
Middle box shows genes, pseudogenes, and TF motifs;
upper blow-out shows gene parts in different modes,
and bottom blow-out shows enhancers with differ-
ent formation mechanisms, i.e., NAHR, NH (nonhomol-
ogous), TEI (transposable element insertion), and
VNTR (variable number of tandem repeats). Aster-
isks indicate significant enrichment (green) or
depletion (red) after multiple hypothesis correction.
SVs intersecting various functional categories in
different modes (e.g., whole/partial) are shown in
the right-hand schematics. (C) Aggregation of his-
tone signal around breakpoints of deletions formed
by different mechanisms. Breakpoints centered at
zero. Aggregation for upstream and downstream re-
gions corresponds to negative and positive distance,
respectively. Signals for an activating histone mark
(H3K4me1) and a repressive mark (H3K27me3) are
shown.
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Another feature of somatic mutations asso-
ciated with their potential role as drivers is their
recurrence in the same genomic element across
multiple cancer samples. We found that some non-
coding elements from our functional categories
show recurrent mutations (fig. S23). For example,
the pseudogene RP5-857K21.6 is mutated in three
out of seven prostate cancer samples, and the
promoter of RP1 is mutated in two (17).
FunSeq: Tool for Identification of Candidate
Drivers in Tumor Genomes
On the basis of the integrative analysis above, we
developed a tool to filter somatic variants from
tumor genomes and obtain a short list of candi-
date driver mutations (funseq.gersteinlab.org).
FunSeq first filters mutations overlapping 1000
Genomes variants and then prioritizes those in
regions under strong selection (sensitive and
ultrasensitive), breaking TF motifs, and those
associated with hubs. It can score the deleterious
0 1 2 3 4
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Fig. 5. Functional implications of positive selection. (A) (Left) Frequency of HighD SNPs versus matched
sites for broad categories (marked by hollow triangles in Fig. 2A). (Right) Specific categories, e.g., specific TF
families. Asterisk denotes significant enrichment after multiple-hypothesis correction. e superscripts in red
denote the enrichment of eQTLs. (B) (Left) The in-degree of genes with HighD missense SNPs is lower than
that of all genes. (Center) The in-degree of genes with HighD SNPs in their promoters is higher than all
genes. (Right) The human regulatory network with edges in gray. Red nodes represent genes with HighD SNPs in their promoters, and blue nodes
represent genes with HighD missense SNPs. Size of nodes scaled based on their degree centrality. Nodes with higher centrality are bigger and tend to
be in the center, whereas those with lower centrality are smaller and tend to be on the periphery.
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Healthy individuals Cancer patients
b. Disruptive
Fig. 6. Functional interpretation of disease variants. (A)
Enrichment of functionally deleterious mutations among somatic
compared with germline SNVs. Mean values from seven prostate
cancer samples shown (variation shown in fig. S16). (B) Ratios for the number of
SNVs that conserve versus break TF-binding motifs depicted for NA12878, the
average of 1000GenomesPhase I samples, and the averageof somatic andgermline
samples from different cancers. Error bars represent 1 SD. MB, medulloblastoma. (C)
Filtering of somatic variants from a breast (PD4006, left) and a prostate (PR-2832,
right) cancer sample leading to identification of candidate drivers. (D) A part of the
FAM48A binding site sequenced by Sanger sequencing in an independent cohort of
19 prostate cancer samples shown in green (with the coordinates of mutations
observed in one sample). (E) Application of variants filtering scheme to Venter
personal genome. Number of SNVs in various categories shown.
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potential of variants in single or multiple genomes
and output the results in easy-to-use formats (i.e.,
“decorated” variant call format files, fig. S29 and
data S6). The scores for each noncoding variant
vary from 0 to 6, with 6 corresponding to maxi-
mum deleterious effect. When multiple tumor ge-
nomes are given as input, FunSeq also identifies
recurrent mutations in the same element. Although
our emphasis is on noncoding variants, it also
outputs scores for coding variants.
We demonstrate the application of FunSeq
as a workflow on representative breast and pros-
tate cancer genomes (Fig. 6C). In the breast cancer
sample, the workflow yielded one noncoding SNV
likely to have strong phenotypic consequences:
This SNV (i) occurs in an ultrasensitive region
(BRF2 binding site); (ii) breaks a PAX-5 TF bind-
ing motif; (iii) is associated with a network hub
(44); and (iv) is recurrent—that is, the regulatory
module contains somatic mutations in multiple
breast-cancer samples. In a similar fashion, the
prostate-cancer sample revealed two noncoding
SNVs predicted to have strong functional conse-
quences (Fig. 6C). One of these is in an ultra-
sensitive region (FAM48A binding site) and lies
in the promoter ofWDR74 gene (a hub in the PPI
network with degree centrality = 56). We further
tested the presence of mutations in this binding
site by polymerase chain reaction followed by
Sanger sequencing in an independent cohort of
19 prostate-cancer samples (45). We found that
one sample in the cohort also harbors mutations
in this region (Fig. 6D and fig. S25). Further-
more, we also observed increased expression of
WDR74 in the tumor relative to benign samples
(fig. S26). These experimental results provide
support for a likely functional role of this candi-
date driver.
A large-scale application of our tool to three
medulloblastoma, 21 breast, and 64 prostate can-
cer genomes provided a total of 98 noncoding
candidate drivers (table S8 and data S6) (17–20).
Among these candidates, 68 occur in sensitive
regions, 55 break TF motifs, and 90 target net-
work hubs.
Generalized Identification of Deleterious
Variants in Personal Genomes
Although we envision the most effective use of
our tool for tumor genomes, it can also be ap-
plied to germline sequences to identify poten-
tially deleterious variants. We applied it to four
personal genomes: Snyder, Venter, NA12878, and
NA19240 (46–48). Out of ~3 million SNVs, we
were able to identify ~15 (range from 6 to 26)
noncoding SNVs per individual with high scores
from FunSeq (>4), indicating their potential del-
eterious effects (Fig. 6E, tables S9 and S10, and
data S6 and S7). Thus, our approach can be used
to prioritize noncoding variants in personal ge-
nomes as well.
Discussion
We identified the sensitive and ultrasensitive non-
coding elements, which exhibit depletion of com-
mon polymorphisms and strong enrichment of
known, inherited disease-causing mutations. Be-
cause they cover a small fraction of the entire
genome (comparable to the exome), these re-
gions can be probed alongside exome sequences
in clinical studies. We found that functionally
disruptive noncoding mutations tend to be under
strong selection: In an analogous manner to LoF
variants in coding genes, variants that break mo-
tifs in TF binding sites are selected against. There
is a close relation between connectivity in biolog-
ical networks and selective constraints: Higher
connectivity is generally associated with higher
constraint. Furthermore, selection against indels
and large SVs acts in a similar fashion as against
SNPs overall; however, the large size of SVs
sometimes leads to a complex relation with func-
tional elements. On the basis of these patterns of
negative selection in functional elements, we de-
veloped a workflow and a corresponding software
tool to prioritize noncoding variants in disease
studies.
The prioritization scheme presented in our
paper can be readily extended by incorporation
of genomic polymorphisms from larger popula-
tions and higher-resolution functional annotations.
Moreover, with the availability of RNA-seq data
from large cohorts, additional genomic features
such as eQTLs can be folded in. Our approach
can be immediately applied in precision medi-
cine studies to prioritize noncoding variants for
follow-up characterization, particularly candidate
driver mutations in cancer, and it can be further
extended in the future.
Materials and Methods
Details of all data sets and methods are provided
in the supplementary materials. A brief summary
of major data sets and methods is provided here.
SNPs, indels, and SVs from 1000 Genomes Phase
I release were used to investigate patterns of selec-
tion in DNA elements (24). Noncoding annota-
tions were obtained from ENCODE Integrative
paper release (2). Although we did analyze broad
functional annotations, such as all TFBSs, we
focused on highly specific categories such as distal
binding sites of factor ZNF274. A randomization
procedure, similar to the Genome Structure Cor-
rection (2), was developed by considering the de-
pendency structure of different categories to deal
with multiple hypothesis correction while iden-
tifying the categories under significantly strong se-
lection. Patterns of somatic mutations were obtained
from seven prostate cancer (17), three medullo-
blastoma (20), and 21 breast cancer genomes
(19), whereas driver mutations were also identi-
fied in additional 57 prostate cancer genomes (18).
References and Notes
1. B. Yngvadottir, D. G. Macarthur, H. Jin, C. Tyler-Smith,
The promise and reality of personal genomics.
Genome Biol. 10, 237 (2009). doi: 10.1186/gb-2009-
10-9-237; pmid: 19723346
2. I. Dunham et al., An integrated encyclopedia of DNA
elements in the human genome. Nature 489, 57–74
(2012). doi: 10.1038/nature11247; pmid: 22955616
3. M. T. Maurano et al., Systematic localization of common
disease-associated variation in regulatory DNA. Science
337, 1190–1195 (2012); 10.1126/science.1222794.
doi: 10.1126/science.1222794; pmid: 22955828
4. L. D. Ward, M. Kellis, Interpreting noncoding genetic
variation in complex traits and human disease.
Nat. Biotechnol. 30, 1095–1106 (2012). doi: 10.1038/
nbt.2422; pmid: 23138309
5. A. Visel et al., Targeted deletion of the 9p21 non-coding
coronary artery disease risk interval in mice. Nature
464, 409–412 (2010). doi: 10.1038/nature08801;
pmid: 20173736
6. W. Lee, P. Yue, Z. Zhang, Analytical methods for inferring
functional effects of single base pair substitutions in
human cancers. Hum. Genet. 126, 481–498 (2009).
doi: 10.1007/s00439-009-0677-y; pmid: 19434427
7. L. D. Ward, M. Kellis, Evidence of abundant purifying
selection in humans for recently acquired regulatory
functions. Science 337, 1675–1678 (2012); 10.1126/
science.1225057. doi: 10.1126/science.1225057;
pmid: 22956687
8. X. J. Mu, Z. J. Lu, Y. Kong, H. Y. Lam, M. B. Gerstein,
Analysis of genomic variation in non-coding elements
using population-scale sequencing data from the
1000 Genomes Project. Nucleic Acids Res. 39,
7058–7076 (2011). doi: 10.1093/nar/gkr342;
pmid: 21596777
9. B. Vernot et al., Personal and population genomics
of human regulatory variation. Genome Res. 22,
1689–1697 (2012). doi: 10.1101/gr.134890.111;
pmid: 22955981
10. S. Horn et al., TERT promoter mutations in familial
and sporadic melanoma. Science 339, 959–961
(2013); 10.1126/science.1230062. doi: 10.1126/
science.1230062; pmid: 23348503
11. F. W. Huang et al., Highly recurrent TERT promoter
mutations in human melanoma. Science 339, 957–959
(2013); 10.1126/science.1229259. doi: 10.1126/
science.1229259; pmid: 23348506
12. P. J. Killela et al., TERT promoter mutations occur
frequently in gliomas and a subset of tumors derived
from cells with low rates of self-renewal. Proc. Natl. Acad.
Sci. U.S.A. 110, 6021–6026 (2013). doi: 10.1073/
pnas.1303607110; pmid: 23530248
13. D. Bell et al., Integrated genomic analyses of ovarian
carcinoma. Nature 474, 609–615 (2011). doi: 10.1038/
nature10166; pmid: 21720365
14. D. M. Muzny et al., Comprehensive molecular
characterization of human colon and rectal cancer.
Nature 487, 330–337 (2012). doi: 10.1038/
nature11252; pmid: 22810696
15. P. S. Hammerman et al., Comprehensive genomic
characterization of squamous cell lung cancers. Nature
489, 519–525 (2012). doi: 10.1038/nature11404;
pmid: 22960745
16. T. J. Hudson et al., International network of cancer
genome projects. Nature 464, 993–998 (2010).
doi: 10.1038/nature08987; pmid: 20393554
17. M. F. Berger et al., The genomic complexity of primary
human prostate cancer. Nature 470, 214–220 (2011).
doi: 10.1038/nature09744; pmid: 21307934
18. S. C. Baca et al., Punctuated evolution of prostate
cancer genomes. Cell 153, 666–677 (2013).
doi: 10.1016/j.cell.2013.03.021; pmid: 23622249
19. S. Nik-Zainal et al., Mutational processes molding the
genomes of 21 breast cancers. Cell 149, 979–993
(2012). doi: 10.1016/j.cell.2012.04.024;
pmid: 22608084
20. T. Rausch et al., Genome sequencing of pediatric
medulloblastoma links catastrophic DNA rearrangements
with TP53 mutations. Cell 148, 59–71 (2012).
doi: 10.1016/j.cell.2011.12.013; pmid: 22265402
21. G. Bejerano et al., Ultraconserved elements in the human
genome. Science 304, 1321–1325 (2004); 10.1126/
science.1098119. doi: 10.1126/science.1098119;
pmid: 15131266
22. R. E. Mills et al., Mapping copy number variation by
population-scale genome sequencing. Nature 470,
59–65 (2011). doi: 10.1038/nature09708;
pmid: 21293372
4 OCTOBER 2013 VOL 342 SCIENCE www.sciencemag.org1235587-8
RESEARCH ARTICLE








23. R. Redon et al., Global variation in copy number in the
human genome. Nature 444, 444–454 (2006).
doi: 10.1038/nature05329; pmid: 17122850
24. G. R. Abecasis et al., An integrated map of genetic
variation from 1,092 human genomes. Nature 491,
56–65 (2012). doi: 10.1038/nature11632;
pmid: 23128226
25. Z. D. Zhang, A. Frankish, T. Hunt, J. Harrow,
M. Gerstein, Identification and analysis of unitary
pseudogenes: Historic and contemporary gene losses in
humans and other primates. Genome Biol. 11, R26
(2010). doi: 10.1186/gb-2010-11-3-r26;
pmid: 20210993
26. P. D. Stenson et al., The Human Gene Mutation
Database: 2008 update. Genome Med 1, 13 (2009).
doi: 10.1186/gm13; pmid: 19348700
27. C. Solis, G. I. Aizencang, K. H. Astrin, D. F. Bishop,
R. J. Desnick, Uroporphyrinogen III synthase erythroid
promoter mutations in adjacent GATA1 and CP2 elements
cause congenital erythropoietic porphyria. J. Clin. Invest.
107, 753–762 (2001). doi: 10.1172/JCI10642;
pmid: 11254675
28. P. Hermanns et al., Consequences of mutations in the
non-coding RMRP RNA in cartilage-hair hypoplasia.
Hum. Mol. Genet. 14, 3723–3740 (2005). doi: 10.1093/
hmg/ddi403; pmid: 16254002
29. M. B. Gerstein et al., Architecture of the human
regulatory network derived from ENCODE data. Nature
489, 91–100 (2012). doi: 10.1038/nature11245;
pmid: 22955619
30. H. B. Fraser, A. E. Hirsh, L. M. Steinmetz, C. Scharfe,
M. W. Feldman, Evolutionary rate in the protein
interaction network. Science 296, 750–752 (2002).
doi: 10.1126/science.1068696; pmid: 11976460
31. E. Khurana, Y. Fu, J. Chen, M. Gerstein, Interpretation
of genomic variants using a unified biological
network approach. PLOS Comput. Biol. 9, e1002886
(2013). doi: 10.1371/journal.pcbi.1002886;
pmid: 23505346
32. X. Wang et al., Three-dimensional reconstruction of
protein networks provides insight into human genetic
disease. Nat. Biotechnol. 30, 159–164 (2012).
doi: 10.1038/nbt.2106; pmid: 22252508
33. P. C. Sabeti et al., Positive natural selection in the
human lineage. Science 312, 1614–1620 (2006).
doi: 10.1126/science.1124309; pmid: 16778047
34. J. Ohashi et al., Extended linkage disequilibrium
surrounding the hemoglobin E variant due to malarial
selection. Am. J. Hum. Genet. 74, 1198–1208 (2004).
doi: 10.1086/421330; pmid: 15114532
35. M. T. Hamblin, A. Di Rienzo, Detection of the signature of
natural selection in humans: Evidence from the Duffy
blood group locus. Am. J. Hum. Genet. 66, 1669–1679
(2000). doi: 10.1086/302879; pmid: 10762551
36. L. B. Barreiro, G. Laval, H. Quach, E. Patin, L. Quintana-Murci,
Natural selection has driven population differentiation
in modern humans. Nat. Genet. 40, 340–345 (2008).
doi: 10.1038/ng.78; pmid: 18246066
37. Y. Xue et al., Population differentiation as an indicator
of recent positive selection in humans: An empirical
evaluation. Genetics 183, 1065–1077 (2009).
doi: 10.1534/genetics.109.107722; pmid: 19737746
38. R. D. Hernandez et al., Classic selective sweeps were rare
in recent human evolution. Science 331, 920–924
(2011). doi: 10.1126/science.1198878; pmid: 21330547
39. S. R. Grossman et al., Identifying recent adaptations in
large-scale genomic data. Cell 152, 703–713 (2013).
doi: 10.1016/j.cell.2013.01.035; pmid: 23415221
40. M. Akiyama et al., Mutations in lipid transporter ABCA12
in harlequin ichthyosis and functional recovery by
corrective gene transfer. J. Clin. Invest. 115, 1777–1784
(2005). doi: 10.1172/JCI24834; pmid: 16007253
41. P. M. Kim, J. O. Korbel, M. B. Gerstein, Positive selection
at the protein network periphery: Evaluation in terms of
structural constraints and cellular context. Proc. Natl.
Acad. Sci. U.S.A. 104, 20274–20279 (2007).
doi: 10.1073/pnas.0710183104; pmid: 18077332
42. R. Haygood, O. Fedrigo, B. Hanson, K. D. Yokoyama,
G. A. Wray, Promoter regions of many neural- and
nutrition-related genes have experienced positive
selection during human evolution. Nat. Genet. 39,
1140–1144 (2007). doi: 10.1038/ng2104;
pmid: 17694055
43. S. B. Carroll, Evo-devo and an expanding evolutionary
synthesis: A genetic theory of morphological
evolution. Cell 134, 25–36 (2008). doi: 10.1016/
j.cell.2008.06.030; pmid: 18614008
44. K. Y. Yip et al., Classification of human genomic regions
based on experimentally determined binding sites of
more than 100 transcription-related factors. Genome
Biol. 13, R48 (2012). doi: 10.1186/gb-2012-13-9-r48;
pmid: 22950945
45. C. E. Barbieri et al., Exome sequencing identifies recurrent
SPOP, FOXA1 and MED12 mutations in prostate cancer.
Nat. Genet. 44, 685–689 (2012). doi: 10.1038/ng.2279;
pmid: 22610119
46. R. M. Durbin et al., A map of human genome variation
from population-scale sequencing. Nature 467,
1061–1073 (2010). doi: 10.1038/nature09534;
pmid: 20981092
47. R. Chen et al., Personal omics profiling reveals
dynamic molecular and medical phenotypes. Cell 148,
1293–1307 (2012). doi: 10.1016/j.cell.2012.02.009;
pmid: 22424236
48. S. Levy et al., The diploid genome sequence of an individual
human. PLoS Biol. 5, e254 (2007). doi: 10.1371/
journal.pbio.0050254; pmid: 17803354
Acknowledgments: We thank G. Boysen and C. O’Reilly for
help with SNV experimental validation, K. Yip for target-gene
identification, and Z. Liu for Web site design. T.H.P. is
supported by the Danish Council for Independent Research
Medical Sciences (FSS). Funding at the European Bioinformatics
Institute is provided by European Molecular Biology
Laboratory and the Wellcome Trust (WT085532 and
WT095908). C.T.-S. acknowledges grant 098051 from the
Wellcome-Trust Sanger Institute. Funding for the Institute for
Precision Medicine (Weill Cornell Medical College/New York
Presbyterian) is provided by National Cancer Institute (NCI)
grant R01CA152057 (A.S., M.G., and M.A.R.) and Early
Detection Research Network NCI U01 CA111275 (M.A.R.).
M.A.R. also thanks the Prostate Cancer Foundation. M.G.
also acknowledges grants HG005718 and HG007000. G.M.
acknowledges National Human Genome Research Institute
grants R01HG4719 and U01HG6513. H.Y. and S.M.L. are
supported by NCI grant CA167824, National Institute of
General Medical Sciences grant GM104424, and a Clinical
and Translational Science Center Pilot Award and Cornell
Seed Grant for intercampus collaborations. H.M.K., T.L.,





Fig. S1 to S29
Tables S1 to S12
References (49–90)
Data S1 to S7
24 January 2013; accepted 23 July 2013
10.1126/science.1235587
www.sciencemag.org SCIENCE VOL 342 4 OCTOBER 2013 1235587-9
RESEARCH ARTICLE








Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics
Dermitzakis, Haiyuan Yu, Mark A. Rubin, Chris Tyler-Smith and Mark Gerstein
Rosenfeld, Cristina Sisu, Xiaomu Wei, Michael Wilson, Yali Xue, Fuli Yu, 1000 Genomes Project Consortium, Emmanouil T. 
Liluashvili, Steven M. Lipkin, Daniel G. MacArthur, Gabor Marth, Donna Muzny, Tune H. Pers, Graham R. S. Ritchie, Jeffrey A.
Fragoza, Erik Garrison, Richard Gibbs, Zeynep H. Gümüs, Javier Herrero, Naoki Kitabayashi, Yong Kong, Kasper Lage, Vaja 
Chakravarty, Daniel Challis, Yuan Chen, Declan Clarke, Laura Clarke, Fiona Cunningham, Uday S. Evani, Paul Flicek, Robert
Lochovsky, Jieming Chen, Arif Harmanci, Jishnu Das, Alexej Abyzov, Suganthi Balasubramanian, Kathryn Beal, Dimple 
Ekta Khurana, Yao Fu, Vincenza Colonna, Xinmeng Jasmine Mu, Hyun Min Kang, Tuuli Lappalainen, Andrea Sboner, Lucas
DOI: 10.1126/science.1235587
 (6154), 1235587.342Science 
regions and thus might indicate mutations that drive cancer.
tended to occur in network hub promoters. Many recurrent somatic cancer variants occurred in noncoding regulatory
general transcription factors (TFs) and core motifs of some important TF families. Positive selection in TF binding sites 
regulatory regions. Noncoding regions under very strong negative selection included binding sites of some chromatin and
polymorphisms from 1092 humans across 14 populations to identify patterns of selection, especially in noncoding 
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